0000934549-16-000102.txt : 20160322 0000934549-16-000102.hdr.sgml : 20160322 20160321181154 ACCESSION NUMBER: 0000934549-16-000102 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160321 ITEM INFORMATION: Other Events FILED AS OF DATE: 20160322 DATE AS OF CHANGE: 20160321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACACIA RESEARCH CORP CENTRAL INDEX KEY: 0000934549 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 954405754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26068 FILM NUMBER: 161519592 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 9494808300 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 8-K 1 a8k_lifeport-endologix.htm 8-K 8-K





UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):          March 17, 2016
ACACIA RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
 
Delaware
000-26068
95-4405754
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
520 Newport Center Drive
Newport Beach, California
92660
(Address of principal executive offices)
(Zip Code)
 
 
Registrant’s telephone number, including area code:       (949) 480-8300
                                                                        Not applicable                         
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[  ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







Item 8.01 Other Events.
 
     LifePort Sciences LLC, LifeScreen Sciences LLC and LifeShield Sciences LLC, subsidiaries of Acacia Research Corporation, entered into a settlement and license agreement with Endologix, Inc. This agreement resolves patent litigation, Civil Action No. 12-cv-1789-GMS, pending in the United States District Court for the District of Delaware.


 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ACACIA RESEARCH CORPORATION
 
 
 
 
 
Date:  March 21, 2016
By:
/s/ Marvin Key
 
 
 
Name: Marvin Key
 
 
 
Title: Chief Executive Officer